Latest Breaking News On - எல்லை சந்தைகள் நிதி - Page 1 : comparemela.com

Targets being tweaked by prepared pharma 20:53 | 09/06/2021 illustration photo. Source: freepik.com According to financial statements from Vietnamese pharma titans like DHG Pharmaceutical JSC, Traphaco JSC, and Imexpharm Pharmaceutical JSC (IMP), there were strong rises in both revenues and profit in the first months of 2021. DHG, the biggest publicly-traded drugmaker, made consolidated revenue of $50 million, up from just over $40 million in the same period last year. Consolidated after-tax profit hit $8.87 million, up 15.24 per cent on-year. Similarly, Traphaco, the country’s second-largest publicly-traded drugmaker, saw on-year rises of 20.87 per cent and 34.06 per cent in consolidated revenue and consolidated after-tax profit respectively during the period. IMP, Vietnam’s fourth-biggest, witnessed a 23.1 per cent on-year increase in before-tax profit in the first four months, while its net revenue rose 9 per cent.

Republic ofSouth koreaThanh luongBì thu nSouth koreanTran tuc maPte ltdSecurities corporationMarket researchTempleton frontier markets fundSuper delta pte ltdCapital investment corporationMagbi fund ltdDevices agencyJapan pharmaceuticalsImexpharm pharmaceutical